Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Report: AI could displace 110,000 Kansas City jobs; here’s who might be most at risk
Editor’s note: This story was originally published by Kansas City PBS/Flatland, a member of the Kansas City Media Collective, which also includes Startland News, KCUR 89.3, American Public Square, The Kansas City Beacon, and Missouri Business Alert. Click here to read the original story. In 2020, when Terrence Wise learned the McDonald’s where he worked would be…
PHKC earns more state funding for 811 Retail Incubator; MTC boosting small biz
Another round of financial support from the Missouri Technology Corporation proves state economic development leaders understand that innovation also runs along main street, said Dan Smith. The Porter House KC — which just opened its 811 Retail Incubator in late July — is among seven entities just awarded a total of $1.8 million in Physical Infrastructure…
MTC just awarded $2.6M in investments; three KC tech startups earn state backing
As Advoteck works to bring its app to market later this year, an equity investment from the Missouri Technology Corporation is expected to help the Kansas City-based startup expand its reach nationwide in the fight against cyber crime. MTC on Tuesday announced $2.6 million in investments across seven Missouri companies — primarily focused on fostering…
KC Chamber, businesses: We won’t back down from DEI initiatives; city’s top diversity advocates honored
LeAna Flores knows those three little letters — DEI — can trigger a lot of people these days, she said. “For me, as a DEI (Diversity, Equity and Inclusion) practitioner, I live and breathe by this quote — especially in the climate that we have right now — ‘They tried to bury us, but they…